Refine
Has Fulltext
- yes (3)
Is part of the Bibliography
- yes (3)
Year of publication
- 2020 (3) (remove)
Document Type
- Doctoral Thesis (3)
Keywords
- Alzheimerkrankheit (1)
- Hypothalamus (1)
- Langzeitgedächtnis (1)
- Neurodegeneration (1)
- Serotonin (1)
- Zebrabärbling (1)
- cadherin-13 (1)
- fgf (1)
- memory enhancement (1)
- neurodevelopment (1)
Angesichts des dramatischen, weltweiten Anstiegs der Prävalenz von Demenzerkrankungen und der aktuellen, unzureichenden Therapieansätze ist die Bereitstellung neuer, wirkungsvoller Behandlungsoptionen von größter Bedeutung. Technologische, pharmakologische und verhaltensbasierte Verfahren des Memory Enhancement könnten zur Lösung dieses Problems beitragen: Hierzu zählt die Stammzelltransplantation, die in mehreren Tierstudien zu einer Verbesserung der Gedächtnisfunktion führte. Zudem wird seit Längerem an einer Impfung gegen die Alzheimer-Krankheit mittels β-Amyloid-Antikörpern geforscht. Ein weiterer therapeutischer Ansatz für die Alzheimer-Krankheit besteht in der optogenetischen Stimulation spezifischer hippocampaler Engramm-Zellen, durch die bei einem Maus-Modell verloren gegangene Erinnerungen wiederhergestellt werden konnten. Unkonventionelle Pharmazeutika wie Erythropoetin führten in Tierstudien und bei Patienten mit neuropsychiatrischen Erkrankungen zu einer Verbesserung der kognitiven Fähigkeiten und des Gedächtnisses. Eine Modifikation der Ernährung und der Einsatz von Pro- und Präbiotika beeinflussen das Gedächtnis über eine Manipulation der Darm-Hirn-Achse. Verhaltensbasierte Maßnahmen wie körperliche Aktivität und der Einsatz von Mnemotechniken stellen effektive Ansätze des Memory Enhancement dar, welche bereits heute von gesunden Individuen implementiert werden können. Für die Anwendung von Augmented Reality (AR) konnten kognitionsfördernde Wirkungen beim Lernen neuroanatomischer Themen und dem Zusammenbau von Objekten nachgewiesen werden. Besonders vielversprechend stellt sich die Entwicklung einer Gedächtnisprothese dar, durch die vergessene Informationen bei Personen mit stattgehabtem Schädel-Hirn-Trauma und apoplektischem Insult reaktiviert werden könnten. Memory Enhancement ist prinzipiell bereits heute bei gesunden und kranken Individuen anwendbar und verspricht wirksame zukünftige Präventions- und Therapieoptionen. Ein realer Einsatz in der klinischen Praxis ist in naher Zukunft jedoch noch nicht zu erwarten.
Serotonin (5-hydroxytryptamine, 5-HT) is a neurotransmitter involved in early
developmental processes such as cell proliferation, migration, and differentiation.
Recent research in humans showed that the brain 5-HT system and CDH13 are
interlinked in the genetics of neurodevelopmental disorders including attention-
deficit/hyperactivity disorder and autism spectrum disorder (Lesch et al., 2008;
Neale et al., 2008; Neale, Medland, Ripke, Anney, et al., 2010; Neale, Medland,
Ripke, Asherson, et al., 2010; Sanders et al., 2011; Sanders et al., 2015; Zhou et
al., 2008). This study introduces Cadherin-13 (CDH13), a cell adhesion protein, as
a contributor to the development and function of the 5-HT system. Our
experiments show that the absence of CDH13 increases the density of 5-HT
neurons in the developing dorsal raphe (DR) and increases the 5-HT innervation
of the prefrontal cortex in mouse embryonic stages. CDH13 is also observed in
radial glial cells, an important progenitor cell type linked to neuronal migration.
A three-dimensional reconstruction carried out with super-resolution microscopy,
identifies 5-HT neurons intertwined with radial glial cells, and CDH13 clusters at
contact points between these cells. This indicates a potential contribution of
CDH13 to the migration of DR 5-HT neurons. As CDH13 is strongly expressed in
5-HT neurons, we asked whether the selective deletion of CDH13 from these cells
is sufficient to generate the alterations observed in the Cdh13 constitutive
knockout mouse line.
In 5-HT conditional Cdh13 knockout mice (Cdh13 cKO) an increase in DR 5-HT
neurons in the embryonic and adult brains is observed, as well as 5-HT
hyperinnervation of cortical regions. Therefore, illustrating that the lack of CDH13
from 5-HT neurons alone impacts DR formation and serotonergic innervation.
Behavioral testing conducted on Cdh13 cKO mice showed delayed learning in
visuospatial learning and memory processing, as well as, changes in sociability
parameters. To find out how CDH13 localizes in human 5-HT neurons, CDH13 was
visualized in neurons that derived from human induced pluripotent stem cells
(iPSC). Super-resolution microscopy confirmed CDH13 expression in a subgroup
of induced human neurons positive for typical hallmarks of 5-HT neurons, such as
expression of Tph2, the neuron-specific tryptophan hydroxylase, and synaptic
structures. In summary, the work included in this thesis presents a detailed
analysis of CDH13 expression and localization in the 5-HT system and shows that
deletion of CDH13 from 5-HT neurons affects specific higher-order functions of the
brain.
This thesis explores the development of monoaminergic systems in the central nervous system (CNS) of zebrafish. The serotonergic cells of the hypothalamus pose the main focus of the present work. Most vertebrates except for mammals possess serotonin (5-HT) synthesising cells in more than one region of the CNS. In zebrafish such regions are, e.g. the hypothalamus, the raphe nuclei and the spinal cord. Serotonin functions as a neurotransmitter and neuromodulator in the CNS. Presumably due to its neuromodulatory tasks hypothalamic serotonergic cells are in contact with the cerebrospinal fluid (CSF), which expands the field of potential serotonergic targets tremendously. This highlights that serotonergic CSF-contacting (CSF-c) cells are vital for the execution of many functions and behaviours. Further, the hypothalamic serotonergic clusters constitute the largest population of serotonergic cells in the CNS of zebrafish. Together, these facts emphasise the need to understand the development and function of serotonergic CSF-c cells in the hypothalamus. Few studies have dealt with this subject, hence, information about the development of these cells is scarce. The zinc-finger transcription factor fezf2, and Fibroblast growth factor (Fgf)-signalling via the ETS-domain transcription factor etv5b are known to regulate serotonergic cell development in the hypothalamus (Bosco et al., 2013; Rink and Guo, 2004). However, the main Fgf ligand responsible for this mediation has not been determined prior to this work. The present thesis identifies Fgf3 as a crucial Fgf ligand. To achieve this result three independent strategies to impair Fgf3 activity have been applied to zebrafish embryos: the fgf3t24152 mutant, an fgf3 morpholino-based knock-down and the CRISPR/Cas9 technique. The investigations show that Fgf3 regulates the development of monoaminergic CSF-c cells in the hypothalamus. Additionally, Fgf3 impacts on cells expressing the peptide hormone arginine vasopressin (avp). Most interestingly, the requirement for Fgf3 by these cells follows a caudo-rostral gradient with a higher dependence on Fgf3 by caudal cells. This also seems to be the case for dopaminergic CSF-c cells in the hypothalamus (Koch et al., 2014). Moreover, etv5b a downstream target of Fgf-signalling is demonstrated to be under the control of Fgf3. With regard to serotonergic CSF-c cell development, it is shown that fgf3 is expressed several hours before tph1a and 5-HT (Bellipanni et al., 2002; Bosco et al., 2013). Together with the result that the hypothalamus is already smaller before mature serotonergic CSF-c cells appear, this argues for an early impact of Fgf3 on serotonergic specification. This hypothesis is supported by several findings in this study: the universal decrease of proliferating cells in the hypothalamus and simultaneous increase of cell death after fgf3 impairment. Complementary cell fate experiments confirm that proliferating serotonergic progenitors need Fgf3 to commit serotonergic specification. Further, these results corroborate findings of an earlier study stating that hypothalamic serotonergic progenitors require Fgf-signalling via etv5b to maintain the progenitor pool (Bosco et al., 2013). Additionally, the transcriptome of the hypothalamus has been analysed and 13 previously overlooked transcripts of Fgf ligands are expressed at developmental stages. The transcriptome analysis provides evidence for a self-compensatory mechanism of fgf3 since expression of fgf3 is upregulated as a consequence of its own impairment. Moreover, the Fgf-signalling pathway appears to be mildly affected by fgf3 manipulation. Together, Fgf-signalling and especially Fgf3 are established to be of critical importance during hypothalamic development with effects on serotonergic, dopaminergic CSF-c and avp expressing cells. Furthermore, this thesis provides two strategies to impair the tph1a gene. Both strategies will facilitate investigations regarding the function of hypothalamic serotonergic CSF-c cells. Finally, the presented findings in this study provide insights into the emergence of the posterior recess region of the hypothalamus, thereby, contributing to the understanding of the evolution of the vertebrate hypothalamus.